Role of fine needle aspiration cytology, cell block preparation and CD63, P63 and CD56 immunostaining in classifying the specific tumor type of the lung.
To determine whether CD63, p63 and CD56 are useful in the diagnostic evaluation of cytologic samples of pulmonary malignancy. We explored the utility of using a panel of 3 antibodies, CD63, p63 and CD56, for the diagnosis of lung cancer in cytologic samples consisting of 40 cases of cell block sections and previously Papanicolaou-stained cytologic smear slides. The positive rates for CD63, p63 and CD56 were as follows: adenocarcinoma (18/19), (0/19), (0/19), for small cell lung carcinoma (3/8), (0/8), (8/8), and for squamous cell carcinoma (0/13), (12/13), (0/13). All p63 positive cases were squamous cell carcinoma, and all CD56 positive cases were small cell lung carcinoma. CD63 was positive in the majority of adenocarcinomas. The panel of CD63, p63 and CD56 appears to be useful in the diagnostic evaluation of cytologic samples of pulmonary malignancy.